# Biocept
 (stock symbol: BIOC) Logo in transparent PNG and SVG formats

## Biocept
 Logo large

### Biocept
 Logo large Download PNG (59.73 KB)

![Biocept
 Logo large Download PNG (59.73 KB)](/img/orig/BIOC_BIG-b41456f3.png)

### Biocept
 Logo large Download SVG (6.78 KB)

![Biocept
 Logo large Download SVG (6.78 KB)](/img/orig/BIOC_BIG-3490f7bc.svg)

## Biocept
 Logo icon format

### Biocept
 Logo icon format Download PNG (32.13 KB)

![Biocept
 Logo icon format Download PNG (32.13 KB)](/img/orig/BIOC-d2975208.png)

### Biocept
 Logo icon format Download SVG (592 Bytes)

![Biocept
 Logo icon format Download SVG (592 Bytes)](/img/orig/BIOC-1648bd24.svg)

## Biocept
 Logo large for dark backgrounds

### Biocept
 Logo large for dark backgrounds Download PNG (36.6 KB)

![Biocept
 Logo large for dark backgrounds Download PNG (36.6 KB)](/img/orig/BIOC_BIG.D-fe7101ef.png)

### Biocept
 Logo large for dark backgrounds Download SVG (6.75 KB)

![Biocept
 Logo large for dark backgrounds Download SVG (6.75 KB)](/img/orig/BIOC_BIG.D-3bde48ea.svg)

## Biocept
 Logo icon format for dark backgrounds

### Biocept
 Logo icon format for dark backgrounds Download PNG (32.13 KB)

![Biocept
 Logo icon format for dark backgrounds Download PNG (32.13 KB)](/img/orig/BIOC.D-8ba4b3b3.png)

### Biocept
 Logo icon format for dark backgrounds Download SVG (592 Bytes)

![Biocept
 Logo icon format for dark backgrounds Download SVG (592 Bytes)](/img/orig/BIOC.D-23eca4e9.svg)

## About Biocept


Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

1. Website domain: biocept.com
2. Employees: 177
3. Marketcap: $4.79 Million USD


## Categories
- [x] üá∫üá∏ United States
- [x] ‚öïÔ∏è Diagnostics and Testing
- [x] üß¨ Biotech
